AAAAAA

   
Results: 1-25 | 26-50 | 51-58 |
Results: 51-58/58

Authors: HEERING P WYES D PLUM J GRABENSEE B
Citation: P. Heering et al., INFLUENCE OF THE RENIN-ANGIOTENSIN SYSTEM AND ATRIAL-NATRIURETIC-PEPTIDE ON RENAL FUNCTIONAL RESERVE, Nephron, 66(1), 1994, pp. 14-20

Authors: HEERING P SCHADEWALDT P BACH D GRABENSEE B
Citation: P. Heering et al., NEPHROTOXICITY OF CYCLOSPORINE IN HUMANS - EFFECT OF CYCLOSPORINE ON GLOMERULAR-FILTRATION AND PROXIMAL TUBULAR REABSORPTION, The Clinical investigator, 71(12), 1993, pp. 1010-1015

Authors: IVENS K HEERING P BACH D GRABENSEE B
Citation: K. Ivens et al., CYCLOSPORINE IN THE TREATMENT OF NEPHROTI C SYNDROME IN PRIMARY GLOMERULONEPHRITIS - APPLICATION, Nieren- und Hochdruckkrankheiten, 22, 1993, pp. 190000018-190000023

Authors: HEERING P WYES D PLUM J GRABENSEE B HEINE H
Citation: P. Heering et al., INFLUENCE OF THE RENIN-ANGIOTENSIN SYSTEM (RAS) ON RENAL FUNCTIONAL RESERVE (RFR), Kidney international, 44(1), 1993, pp. 239-239

Authors: BRAUN N PRZECHERA M WEBER A MULLER GA ERLEY C HEERING P ZAUNER I GRUPP C FUNFSTUCK R FRANZ HE SCHOLLMEYER P GRABENSEE B STEIN G RISLER T
Citation: N. Braun et al., THERAPY OF THE MEMBRANOUS GLOMERULONEPHRITIS WITH NEPHROTIC SYNDROME - A PROSPECTIVE, RANDOMIZED MULTICENTER STUDY, Kidney international, 44(1), 1993, pp. 249-250

Authors: HEERING P GRABENSEE B
Citation: P. Heering et B. Grabensee, IS THE CREATININE CLEARANCE A MARKER FOR GFR IN RENAL GRAFT RECIPIENTS TREATED WITH CYCLOSPORINE (CSA), Kidney international, 44(1), 1993, pp. 255-255

Authors: WESTHOFF A HEERING P IVENS K KOCH M GRABENSEE B
Citation: A. Westhoff et al., CYCLOSPORINE OR AZATHIOPRINE FOLLOWING TRIPLE THERAPY - A PROSPECTIVERANDOMIZED STUDY, Kidney international, 44(1), 1993, pp. 255-255

Authors: KEMMER FW BLOEM J HEERING P REINHARD T GRABENSEE B
Citation: Fw. Kemmer et al., EFFECTS OF CYCLOSPORINE ON LIPID-METABOLISM, Kidney international, 44(1), 1993, pp. 255-255
Risultati: 1-25 | 26-50 | 51-58 |